Exploring biomarkers for cognitive disorders in China
Official title: Cohort Study on Biomarkers of Cognitive Disorders in China
Run by Xuanwu Hospital, Beijing · NCT06419101 · Data updated 2026-11-12
This study is trying to find early signs of dementia by following 3,000 people in China who have different stages of memory problems to see how their condition changes over time.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 40 Years to 90 Years |
| Sex | All |
| Enrollment | 3000 (estimated) |
| Sponsor | Xuanwu Hospital, Beijing Academic / other |
| Locations | 1 site (Beijing) |
| Status | Recruiting |
| Started | May 30, 2024 |
| Main results expected | May 10, 2034 |
| Study ends | May 10, 2035 |
| Registry record updated | November 14, 2024 |
| Trial ID | NCT06419101 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are Chinese individuals aged 40 to 90 who exhibit signs of cognitive decline.
✕Probably not a fit
Patients with severe cognitive impairment or other neurological diseases that could confound results may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to establish a large-scale dementia cohort in China by enrolling 3000 patients with pre-dementia stages and various dementia subtypes. It will collect comprehensive data, including demographics, clinical symptoms, neuropsychological assessments, neuroimaging, and biological samples. Participants will undergo annual follow-ups to monitor changes in their cognitive status, allowing researchers to compare clinical phenotypes and identify potential biomarkers for early diagnosis and progression of dementia. The study seeks to address the lack of longitudinal data on cognitive decline in the Chinese population.
Why it matters
Potential benefit: If successful, this study could lead to improved diagnostic methods and early intervention strategies for dementia, enhancing patient outcomes.
How similar studies have gone: Other studies have successfully established dementia cohorts and identified biomarkers, suggesting that this approach has potential for success.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Male or female patients aged ≥40 and ≤90years; * Chief complaint or others describe a cognitive decline; * Ability to communicate in Chinese; * The patients and their families were informed and signed the informed consent. Exclusion Criteria: * MMSE\<10; * There are other neurological diseases that can cause brain dysfunction (such as depression, brain tumors, Parkinson's disease, metabolic encephalopathy, encephalitis, multiple sclerosis, epilepsy, traumatic brain injury, normal intracranial pressure hydrocephalus, etc.); * There are other systemic diseases that can cause cognitive impairment (such as hepatic insufficiency, renal insufficiency, Thyroid dysfunction, severe anemia, folic acid or vitamin B12 deficiency, syphilis, HIV infection, alcohol and drug abuse, etc.); * Suffering from a disease that cannot cooperate with the completion of cognitive examination; * There are contraindications to nuclear magnetic resonance; * There is mental and neurodevelopmental delay; * Refuse to draw blood; * Refuse to sign the informed consent.
Where it's running
-
Capital Medical University Xuanwu Hospital
Beijing, China Recruiting
Study contacts
- Principal investigator: Cuibai Wei — Xuan Wu Hospital of Capital Medical University, Beijing, China, 100053
- Study coordinator: Cuibai Wei
- Email: weicb@xwhosp.org
- Phone: 83198319
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Diabetes, Dementia, and Oxidative Stress: A look at Nox2-related markers
This study tests whether oxidative stress linked to Nox2 is related to dementia risk in adults with type 2 diabetes.
-
China HEAD: a large community study on healthy aging and dementia
This study tests whether collecting health, imaging, and biospecimen data from adults in China can help predict who will develop Alzheimer’s disease and related dementias.
-
Doll Therapy for Apathy and Daily Living in Older Adults with Dementia
This study tests whether doll therapy helps reduce apathy and improves starting daily activities in older adults with dementia.
-
Aging Brain Health Initiative in Fujian
This observational study will follow about 3,000 older adults in Fujian to see how Alzheimer's-related changes develop and to test new digital tests, biomarkers, and imaging tools for early diagnosis.
-
One-day exercise test to see how brain and body react in epilepsy, cognitive disorders, Parkinson's, dementia, and related conditions
A one-day study tests how an acute bout of exercise changes brain function and bodily signals in people with certain neurological conditions compared with healthy individuals.
-
Blood biomarker cohort for memory disorders in older adults
This observational cohort will collect blood samples and brain imaging data from adults 50+ with memory disorders and a small group of healthy young adults to help find biomarkers.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.